Abbott (NYSE: ABT) reported Q2 EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $11.42 billion versus the consensus estimate of $11.07 billion.

GUIDANCE:

Abbott sees FY2025 EPS of $5.10-$5.20, versus the consensus of $5.16.

For earnings history and earnings-related data on Abbott (ABT) click here.